+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiovascular Drugs Market Research Reports

Tachycardia (Tachyarrhythmias) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Tachycardia (Tachyarrhythmias) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • September 2021
  • 213 Pages
  • Global
From
Structural Heart Occluders Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies - Product Thumbnail Image

Structural Heart Occluders Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies

  • Report
  • November 2023
  • 104 Pages
  • Global
From
Heart Failure Epidemiology Analysis and Forecast to 2032 - Product Thumbnail Image

Heart Failure Epidemiology Analysis and Forecast to 2032

  • Report
  • September 2023
  • 75 Pages
  • Global
From
Venous Thromboembolism (VTE) Epidemiology Analysis and Forecast to 2032 - Product Thumbnail Image

Venous Thromboembolism (VTE) Epidemiology Analysis and Forecast to 2032

  • Report
  • June 2023
  • 57 Pages
  • Global
From
Dyslipidemia Epidemiology Analysis and Forecast to 2032 - Product Thumbnail Image

Dyslipidemia Epidemiology Analysis and Forecast to 2032

  • Report
  • May 2023
  • 57 Pages
  • Global
From
Myocardial Infarction (MI) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Myocardial Infarction (MI) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • April 2023
  • 78 Pages
  • Global
From
Aneurysm Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update - Product Thumbnail Image

Aneurysm Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update

  • Report
  • March 2023
  • 187 Pages
  • Global
From
Pulmonary Arterial Hypertension Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029 - Product Thumbnail Image

Pulmonary Arterial Hypertension Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2019-2029

  • Drug Pipelines
  • December 2022
  • 107 Pages
  • Global
From
Structural Heart Occluders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update - Product Thumbnail Image

Structural Heart Occluders Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update

  • Report
  • November 2022
  • 94 Pages
  • Global
From
Acute Ischemic Stroke Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Acute Ischemic Stroke Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • November 2022
  • 565 Pages
  • Global
From
Vasculitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Vasculitis Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • July 2022
  • 68 Pages
  • Global
From
Cardiomyopathies Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 - Product Thumbnail Image

Cardiomyopathies Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  • Drug Pipelines
  • June 2022
  • 101 Pages
  • Global
From
Critical Limb Ischemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Critical Limb Ischemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • May 2022
  • 208 Pages
  • Global
From
Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Familial Hypercholesterolemia (Type II Hyperlipoproteinemia) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • May 2022
  • 471 Pages
  • Global
From
Diastolic Heart Failure Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Diastolic Heart Failure Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • April 2022
  • 204 Pages
  • Global
From
Hypercholesterolemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update - Product Thumbnail Image

Hypercholesterolemia Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2022 Update

  • Report
  • March 2022
  • 1284 Pages
  • Global
From
Atrial Fibrillation - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Atrial Fibrillation - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 929 Pages
  • Global
From
Homozygous Familial Hypercholesterolemia (HoFH) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Homozygous Familial Hypercholesterolemia (HoFH) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 259 Pages
  • Global
From
Heterozygous Familial Hypercholesterolemia (heFH) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Heterozygous Familial Hypercholesterolemia (heFH) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • August 2021
  • 276 Pages
  • Global
From
Heterozygous familial hypercholesterolemia (heFH) Disease - Global Clinical Trials Review, H1, 2021 - Product Thumbnail Image

Heterozygous familial hypercholesterolemia (heFH) Disease - Global Clinical Trials Review, H1, 2021

  • Clinical Trials
  • February 2021
  • 263 Pages
  • Global
From
Loading Indicator

The Cardiovascular Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat cardiovascular diseases. These drugs are used to treat conditions such as hypertension, coronary artery disease, congestive heart failure, and arrhythmias. Cardiovascular drugs are also used to reduce the risk of stroke, heart attack, and other cardiovascular events. The market is composed of a variety of companies, ranging from large multinationals to small start-ups. Major players in the market include Pfizer, Merck, Novartis, Sanofi, and Bristol-Myers Squibb. These companies are involved in the research, development, and production of cardiovascular drugs. Additionally, there are a number of smaller companies that specialize in the production of generic cardiovascular drugs. These companies include Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more